BeiGene’s (BGNE) BTK-targeting chimeric degradation activation compound designed to degrade wildtype BTK and multiple mutant forms received FDA orphan designation in treatment of Waldenstrom ...
Consumers who take copies of the popular weight loss and diabetes drug tirzepatide will likely need to find a new source for these medications early next year. On Thursday, the Food and Drug ...
The proposal from the Food and Drug Administration and mandated by Congress is intended to reassure consumers about the safety of makeup, baby powder and other personal care products. It follows ...
Orphan designation was granted by the FDA to Curis (CRIS) Inc’s emavusertib for the treatment of primary central nervous system lymphoma, according to a post to the agency’s website.
The U.S. Food and Drug Administration has announced a final rule to update the definition of the nutrient content claim “healthy.” According to the FDA, there is an ever-growing crisis of ...
The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...
On Sept. 25, the U.S. Food and Drug Administration (FDA) hosted a public meeting to gather feedback on its proposed framework for an enhanced systemic post-market assessment process for chemicals in ...
rummy ares logo Nature's latest report: Breast cancer drug market is expected to reach $47.7 billion in 2029 A new round of reshuffle has begun! When will the next shoe of the pharmaceutical industry ...
have welcomed the Food and Drug Administration's (FDA) certification of Camellia sinensis tea as a healthy beverage. This landmark verdict supports the global tea industry's assertions about the ...
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed. Recent ...